Bioventus BVS Finance Lease, Right-of-Use Asset, after Accumulated Amortization
Finance Lease, Right-of-Use Asset, after Accumulated Amortization at other companies
Other financials
Where this comes from
Reported directly by Bioventus in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseRightOfUseAsset.
The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bioventus's finance lease, right-of-use asset, after accumulated amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bioventus's finance lease, right-of-use asset, after accumulated amortization?
- Bioventus (BVS) reported finance lease, right-of-use asset, after accumulated amortization of $10.84M in Q1 2026.
- How has Bioventus's finance lease, right-of-use asset, after accumulated amortization changed year-over-year?
- Bioventus's finance lease, right-of-use asset, after accumulated amortization decreased by 12.5% year-over-year, from $12.38M to $10.84M.
- What is the long-term trend for Bioventus's finance lease, right-of-use asset, after accumulated amortization?
- Over 3 years (2022 to 2025), Bioventus's finance lease, right-of-use asset, after accumulated amortization has grown at a 344.2% compound annual growth rate (CAGR), from $128K to $11.22M.